Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00904553 · ClinicalTrials.gov registry record
Study of Resection Combined With Stereotactic Radiosurgery for 1 to 3 Brain Metastases
A clinical trial of Neoplasm Metastasis, sponsored by University of Rochester.
- Completed
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT00904553: Completed study of Neoplasm Metastasis, sponsored by University of Rochester.
NCT00904553 is a study of Neoplasm Metastasis that has completed, run by University of Rochester. The registered enrollment target is 25 participants, below the 415-participant average among 41 other Neoplasm Metastasis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00904553, a study of Neoplasm Metastasis, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is to look more closely at the tumor removed during your surgery, and to follow your condition after your treatment. The purpose of this study is to determine what side effects are common or more rare from this treatment, how well the treatment has worked for you, and to track whether you develop other brain metastases.
Conditions Studied
Interventions
- RADIATION Novalis Shaped Beam Surgery
Study Locations (1)
New York
- Department of Radiation Oncology, University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2009-01-14 |
| Est. Completion | 2022-03-28 |
What the finished NCT00904553 record still lists
NCT00904553 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 415-participant average among 41 other Neoplasm Metastasis trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Neoplasm Metastasis appearing as the primary indexed condition, and to 1 intervention - of which Novalis Shaped Beam Surgery is the first listed.
NCT00904553 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00904553 about?
NCT00904553 is a clinical study titled "Study of Resection Combined With Stereotactic Radiosurgery for 1 to 3 Brain Metastases". This study is to look more closely at the tumor removed during your surgery, and to follow your condition after your treatment. The purpose of this study is to determine what side effects are common or more rare from this treatment, how well the treatment has worked for you, and to track whether yo...
What is the current status of trial NCT00904553?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2009-01-14. Estimated completion is 2022-03-28.
What conditions does trial NCT00904553 study?
This clinical trial studies the following conditions: Neoplasm Metastasis.
What interventions are being tested in trial NCT00904553?
The interventions under investigation include: Novalis Shaped Beam Surgery (RADIATION).
Who is sponsoring clinical trial NCT00904553?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00904553 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neoplasm Metastasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00904553's enrollment target sits among peer trials
25 38th of 41 higher than 4 of 41 other Neoplasm Metastasis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neoplasm Metastasis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RECRUITING · Phase 3
-
EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers
RECRUITING · Phase 1
-
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
RECRUITING · Phase 1
-
A Study of LY4175408 in Participants With Advanced Cancer
RECRUITING · Phase 1
-
Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases
RECRUITING · NA
-
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI